Compounds useful as CDK2 / 4
protein kinase inhibitors and uses thereof are provided. Specifically, provided are compounds of formula I, or pharmaceutically acceptable salts, stereoisomers, tautomers, hydrates, solvates,
isotope compounds or prodrugs thereof, in which the definitions of each group and
substituent group are as described in the specification, and which are useful as inhibitors of
cyclin dependent kinases (CDKs), in particular as inhibitors of
Cyclin dependent kinases (CDKs), as well as inhibitors of
Cyclin dependent kinases (CDKs), as well as inhibitors of
Cyclin dependent kinases (CDKs). The compound is used for preventing or treating
cell proliferative diseases and symptoms including various cancers, and is particularly used for regulating and / or treating related diseases caused by overexpression and / or abnormal activity of
cyclin-dependent
kinase CDK2 / 4.